Posts Tagged ‘OHSU Knight Cancer Institute’

Research finds prostate cancer patients helped by targeted exercise

Men being treated for prostate cancer through androgen deprivation therapy, or ADT, face a troubling problem: The loss of bone and muscle mass while gaining fat.  The side effects of this treatment put them at risk for heart disease, frailty, and broken bones. But a first-of-its-kind randomized clinical trial is providing evidence that targeted exercise can slow bone loss, reverse muscle weakness, and prevent gains in body fat in men undergoing ADT. Kerri Winters-Stone, Ph.D., … Read More

Knight Cancer Institute researchers track metastasis with cell-free DNA

Researchers at the OHSU Knight Cancer Institute recently found that sequencing the fragments of tumor DNA that circulate in blood may give a more accurate picture of a patient’s metastatic cancer than can be obtained from biopsies. Paul Spellman, Ph.D., professor of molecular and medical genetics at OHSU, led the study, which showed that whole-exome sequencing of cell-free DNA can find the same clinically relevant mutations identified in DNA from tumor tissue, and it can … Read More

In case you missed it: Updates from the Knight Cancer Institute

Testing the impact of reference pricing on cancer care More than 15 million colonoscopies are performed in the U.S. each year as a routine cancer-prevention service, but did you know that the price for this procedure can vary by more than tenfold within a metropolitan area? David Lieberman, M.D., discusses the impact of reference pricing for colonoscopy services in a commentary in JAMA Internal Medicine. Find out more on Knight News. MicroRNA as an early … Read More

Video lecture: The Philadelphia chromosome and the search for a cure

The first week of May shone a spotlight on research at OHSU at the institution’s annual Research Week. Part of the programming included a lecture by science writer and author Jessica Wapner, whose book “The Philadelphia Chromosome: A Mutant Gene and the Quest to Cure Cancer at the Genetic Level” chronicles the true story of a scientist’s landmark discovery that helped identify the sole cause of a deadly blood cancer. The Philadelphia chromosome turned cancer research … Read More

Medical Research Foundation honors top Oregon scientists, mentors

The Medical Research Foundation of Oregon has announced the recipients of its 2014 awards for scientific leadership and innovation in Oregon. The awards were presented Wednesday, Nov. 12. Established in 1942, the MRF promotes medical research achievement across the state. In addition to awarding its annual leadership and innovation honors, it administers more than $1 million in annual research funding and early investigator grants that support the work of outstanding investigators at research institutions across … Read More

The American Society of Hematology recognizes Grover Bagby, M.D.

The American Society of Hematology will honor Grover C. Bagby Jr., M.D., with a 2014 Mentor Award at the 56th Annual ASH Meeting and Exposition in San Francisco for his sustained, outstanding commitment to the training and career development of early-career hematologists. Dr. Bagby, professor of medicine and molecular and medical genetics in the OHSU School of Medicine, and founding director of the OHSU Knight Cancer Institute, will be presented with the award for his … Read More

New search tool for tissue samples available for cancer researchers

The OHSU Knight BioLibrary recently introduced a biolocator search engine that provides cancer researchers with a new tool for requesting specimens. For the first time, researchers—whether at OHSU or outside institutions—can do an online search of the repositories that are part of the BioLibrary. The eight searchable repositories currently contain more than 100,000 specimens from about 8,600 patients. Highlights include: Automated process: All specimen requests are now handled directly through the search engine. After each submission, researchers can log onto the … Read More

PancWest Symposium, Sept. 5-6

The OHSU Brenden-Colson Center for Pancreatic Care and the OHSU Knight Cancer Institute are pleased to announce the inaugural PancWest Symposium, an interactive scientific meeting covering the latest advances and current obstacles in pancreatic cancer research and patient care.  Topics to be covered include advances in clinical patient care, a forum to discuss barriers to further progress, interactive workshops to discuss collaborative research and funding opportunities, and more. View a list of confirmed speakers. PancWest … Read More

Diversity focus: Research interns get hands-on lab experiences

The Center for Diversity and Inclusion thanks research faculty and postdoc fellows who are serving as mentors to the research interns who are part of the Ted R. Lilley Cancer CURE and Summer Equity internship programs. This summer, CDI has placed 26 high school and college students in research lab experiences throughout OHSU. The highly competitive programs drew over 200 applicants from across Oregon and the United States. Interns receive a stipend during their time … Read More

Jeffrey Tyner, Ph.D., receives prestigious early-career award from AAAS

Jeffrey Tyner, Ph.D., an assistant professor of cell and developmental biology in the OHSU School of Medicine and a member of the Knight Cancer Institute, is one of two recipients of the 2nd Annual Martin and Rose Wachtel Cancer Research Award from the American Association for the Advancement of Science (AAAS). Dr. Tyner received the award for research that simultaneously identifies cancer-causing mutations and drugs that target these mutations. Dr. Tyner’s award essay was published … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.